Related Experiment Video
Updated: Aug 28, 2025

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
Published on: January 31, 2022
Late-Onset Acute Liver Injury From Azathioprine
Benjamin Schwartz1, Ram Al-Sabti1, Nancy Reau1
1Rush University Medical Center, Chicago, IL.
Abstract:
Azathioprine is a widely prescribed immunosuppressant. Although hepatotoxicity is rare, it commonly presents as mild asymptomatic liver enzyme elevation or acute cholestatic liver injury. We report a case of a 46-year-old woman who presented with jaundice, abdominal pain, fatigue, and elevated aminotransferases in a cholestatic pattern. Endoscopic retrograde cholangiopancreatogram demonstrated no abnormalities, and recently started medications were discontinued without improvement. Liver biopsy was performed, which was consistent with drug-induced liver injury. Despite multiple years of treatment without issue, after azathioprine was discontinued, symptoms and laboratory abnormalities resolved. This case highlights azathioprine's potential for hepatotoxicity even multiple years after initiation.
More Related Videos
Related Concept Videos
Acute Kidney Injury III: Clinical Manifestations
Drugs for Treatment of Ulcerative Colitis in IBD
Acute Kidney Injury I: Introduction
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology

